Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.

Posted:
7
December 2009

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.The AHPPI is an informal cross-industry discussion group whose purpose is to address issues facing those involved in early phase drug development and to educate members through directed symposia at each of its 2 meetings per year.The Association has been in existence for over nearly 2 decades and has forged links with both other scientific societies with similar interests and with professional bodies such as the ABPI and ICR.   For several years, the association has been organising joint biannual meetings with the clinical section of the British Pharmacological Society , all of which have been very successful and will continue in the future.This year s AHPPI Annual Winter meeting will be hosted at St George s Hospital, University of London, Tooting and will take place on 4th February 2010. We kindly invite all members of the AHPPI as well as those who are not members and keen to attend, to join us on the day.The meeting has recently been awarded 3 CPD points by the Faculty of Pharmaceutical Physicians.The topic of discussion will be �Current Advances in the Development of Vaccines and Biopharmaceuticals: A Challenge not be Sneezed at?� and there is an exciting list of key speakers already lined up for the day, namely;�    Professor David Lewis, St George�s Vaccine Institute�    Dr Afshan Ahmad, Vaccine Research International�    Dr Simon Beddows, Health Protection Agency�    Dr Azharul Mannan, Sanofi Pasteur MSD�    Professor Geoff Hale, BioAnaLab�    Professor John Oxford, Retroscreen Virology Ltd.�    Andrew Nolan, QuintilesFor further details for what�s in store for the day, please click here to view the meeting agenda.If you would like to register for this meeting; please complete our online registration form.If you would like to request more information, please email us at info@richmondpharmacology.com or complete our online enquiry form.Registrations for AHPPI members: �20.00Registrations for non-members: �50.00

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next year.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more